Recombinant Human EDN2 Protein，His

EDN2, or Endothelin-2, is a critical peptide belonging to the endothelin family, known for its potent vasoconstrictive properties and roles in various physiological processes, such as angiogenesis and cellular proliferation. Originally identified as a product of endothelial cells, EDN2 has garnered attention due to its involvement in pathological conditions, including cardiovascular diseases, cancer, and pulmonary disorders. Research has demonstrated that EDN2 can influence cell signaling pathways through its interaction with endothelin receptors, leading to diverse biological effects that are significant in both health and disease. Moreover, advancements in recombinant protein technologies have enabled the production of EDN2 for further functional studies, facilitating the exploration of its mechanisms in cellular environments. Investigating EDN2's role in disease conditions offers potential therapeutic insights and targets, making it an important focus within the fields of molecular biology and pharmacology. Understanding the biological functions and regulatory mechanisms of EDN2 is crucial for developing innovative strategies for disease intervention and improving patient outcomes. Furthermore, studies on EDN2's interactions at the molecular level can enhance our comprehension of endothelial biology and its implications in various pathological states.